Results 11 to 20 of about 662,222 (250)

Drug-induced dyskinesias, can they be prevented? [PDF]

open access: yesCurrent Problems of Psychiatry, 2020
Abstract Introduction: Dyskinesia is a symptom complex in the form of involuntary, repetitive movements of lips, lower jaw, tongue, less often the trunk and limbs. Despite the use of newer drugs in treatment neuroleptics, dyskinesia has not ceased to be a clinical problem.
Romaniuk, Małgorzata   +3 more
openaire   +2 more sources

Drug-Induced Dyskinesia Treated with Korean Medicine: A Case Report

open access: yesJournal of Acupuncture Research, 2023
Drug-induced dyskinesia is an involuntary muscle movement caused by various dopamine receptor-blocking drug exposure, such as antipsychotics, antidepressants, and antiemetics.
Soo Min Ryu   +6 more
doaj   +1 more source

Abdominal Wall Dyskinesia in a Child Presenting as Belly Dancers’ Syndrome: A Case Report

open access: yesJournal of Nepal Medical Association, 2023
Belly dancer’s dyskinesia or syndrome is a rare condition characterized by involuntary, undulating, infrequent diaphragm movements. The etiologies for this disorder include nervous system disorders (peripheral or central), drug-induced, psychological ...
Divya KC   +4 more
doaj   +1 more source

Drug-Induced Tardive Dyskinesia

open access: yesInternational Journal of Research and Review, 2021
Drug-induced movement disorders could be classified into acute, subacute, and chronic based on the time of occurrence. Tardive dyskinesia (TD) is one of the most frequent long-term drug-induced movement disorders. Delay in treatment often caused TD to be irreversible.
Marianto Marianto   +2 more
openaire   +1 more source

Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by l‐DOPA in hemiparkinsonian rats

open access: yesBritish Journal of Pharmacology, 2021
l‐DOPA‐induced dyskinesia is a debilitating effect of treating Parkinson's disease with this drug. New therapeutic approaches that prevent or attenuate this side effect are needed.
M. Bortolanza   +3 more
semanticscholar   +1 more source

Belly dancer syndrome improved by withdrawal of droxidopa and amantadine

open access: yesClinical Case Reports, 2023
Key Clinical Message A man hospitalized for cerebral infarction developed drug‐induced belly dancer syndrome, which improved after withdrawal of droxidopa and amantadine.
Mihiro Kaga   +6 more
doaj   +1 more source

Efficacy of low-dose pramipexole augmentation in the treatment of refractory psychotic depression complicated with tardive dyskinesia: a case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Tardive dyskinesia (TD) is a severe complication of antipsychotic treatment. Pramipexole can be effective in the treatment of TD due to its D3 dopamine receptor agonist effect.
Arzu Erkan   +3 more
doaj   +1 more source

Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson’s disease

open access: yesPLoS ONE, 2020
A higher levodopa dose is a strong risk factor for levodopa-induced dyskinesia (LID) in patients with Parkinson’s disease (PD). However, levodopa dose can change during long-term medication.
J. Hong   +6 more
semanticscholar   +1 more source

Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2016
Objective(s):Long-term treatment with antipsychotics causes serious side effects such as tardive dyskinesia that characterized by abnormal movements in the orofacial region. Oxidative stress in the brain specific area is implicated in the pathophysiology
Marzyeh Kamyar   +5 more
doaj   +1 more source

Failure of pyridoxine to reduce drug-induced dyskinesias [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 1970
The use of pyridoxine seems to be ineffective in reducing tardive dyskinesia.
G E, Crane, I S, Turek, A A, Kurland
openaire   +2 more sources

Home - About - Disclaimer - Privacy